S. Grimm

Use of Cationic Lipids to Enhance the Biological Activity of Antisense Oligonucleotides

C. Bennett, M. Chiang, H. Chan, 1993 .

Chemical Modification of Hammerhead Ribozymes

A. Karpeisky, N. Usman, L. Beigelman, 1995, The Journal of Biological Chemistry.

Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse.

S. Grimm, T. Parry, P. Pavco, 1999, Antisense & nucleic acid drug development.

2′-SUBSTITUTED PHOSPHOROTHIOATE CONTAINING OLIGORIBONUCLEOTIDES: AN APPLICATION TO THE SYNTHESIS AND PURIFICATION OF HAMMERHEAD RIBOZYMES

L. Maloney, N. Usman, S. Grimm, 1996 .

Dose and Load Studies for Subcutaneous and Oral Delivery of Poly(lactide-co-glycolide) Microspheres Containing Ovalbumin

T. Uchida, S. Grimm, R. Wardley, 1994, Pharmaceutical Research.

Synthesis, deprotection, analysis and purification of RNA and ribozymes.

S. Scaringe, N. Usman, S. Grimm, 1995, Nucleic acids research.

Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.

C. Bennett, M. Chiang, H. Chan, 1994, Journal of immunology.

Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.

S. Grimm, K. Blanchard, K. Jensen, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Crystal structures of an A-form duplex with single-adenosine bulges and a conformational basis for site-specific RNA self-cleavage.

N. Usman, M. Egli, S. Grimm, 1996, Chemistry & biology.

Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.

S. Grimm, K. Blanchard, K. Jensen, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Purification and properties of an accessory protein for DNA polymerase alpha/primase.

M. Goulian, S. Grimm, S. Grimm, 1990, The Journal of biological chemistry.